Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Get Quote
Search InvestCenter
Recent Quotes
First Merchants Corporation - Common Stock
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by Tetra Bio-Pharma
Health Canada Accepts New Drug Submission for REDUVO(TM) as a Treatment for Patients with Chemotherapy-induced Nausea and Vomiting
June 02, 2021
From
Tetra Bio-Pharma
Via
AccessWire
Topics
Cannabis
Intellectual Property
Tickers
TBPMF
TSX:TBP
Tetra Bio-Pharma Accelerates PLENITUDE(C) Clinical Trial to Evaluate the Effect of Cannabis for Use in Managing Uncontrolled Cancer Pain
May 11, 2021
From
Tetra Bio-Pharma
Via
AccessWire
Topics
Cannabis
Intellectual Property
Tickers
TBPMF
TSX:TBP
Tetra Bio-Pharma Announces Start of the REBORN1(C) Clinical Trial
May 06, 2021
From
Tetra Bio-Pharma
Via
AccessWire
Topics
Cannabis
Intellectual Property
Tickers
TBPMF
TSX:TBP
Tetra Bio-Pharma Signs a Definitive Distribution Agreement with DanCann Pharma to Monetize Its Dronabinol and Botanical Product Portfolios
May 05, 2021
From
Tetra Bio-Pharma
Via
AccessWire
Topics
Cannabis
Intellectual Property
Tickers
TBPMF
TSX:TBP
Tetra Bio-Pharma Re-activates Veterinary Clinical Study in Companion Animals
May 04, 2021
From
Tetra Bio-Pharma
Via
AccessWire
Topics
Cannabis
Intellectual Property
Tickers
TBPMF
TSX:TBP
Tetra Bio-Pharma Granted a Drug Establishment License to Distribute REDUVO Soft Gel Capsules in Canada
May 03, 2021
From
Tetra Bio-Pharma
Via
AccessWire
Topics
Cannabis
Intellectual Property
Tickers
TBPMF
TSX:TBP
Tetra Bio-Pharma Submits Request for Scientific Advice to Malta Medicines Authority
April 28, 2021
From
Tetra Bio-Pharma
Via
AccessWire
Topics
Intellectual Property
Tickers
TBPMF
TSX:TBP
Tetra Bio-Pharma Provides an Update on its U.S. REBORN1 Clinical Trial
April 23, 2021
From
Tetra Bio-Pharma
Via
AccessWire
Topics
Cannabis
Intellectual Property
Tickers
TBPMF
TSX:TBP
Tetra Bio-Pharma Announces Granting of U.S. Patent for Treatment of Interstitial Cystitis
April 15, 2021
From
Tetra Bio-Pharma
Via
AccessWire
Topics
Intellectual Property
Tickers
TBPMF
TSX:TBP
Tetra Bio-Pharma Provides Update on Its New Drug Submission Application in Canada
April 14, 2021
From
Tetra Bio-Pharma
Via
AccessWire
Topics
Intellectual Property
Tickers
TBPMF
TSX:TBP
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.